Home > Boards > US OTC > Retail - Wholesale Distributors > MC Endeavors (MSMY)

Video Interview w/ CEO of $MSMY Steven Mazurek:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
U GOT TRUMPED Member Profile
Member Level 
Followed By 28
Posts 5,459
Boards Moderated 3
Alias Born 11/29/16
160x600 placeholder
U GOT TRUMPED Member Level  Friday, 07/23/21 08:38:47 PM
Re: None
Post # of 59803 
Video Interview w/ CEO of $MSMY Steven Mazurek: Released today by Truthful Trading. http://truthfultrading.com/




LINK--->> https://youtu.be/-Mswcf51kb0

$MSMY A Transparent GEM with millions in rev booming Q over Q and profitable with ZERO dilution in very hot CBD sector (white label wholesale manufacturer).

$MSMY #44 out of 100 Best Private Label CBD Manufacturers and Suppliers In The World! (posted April 20th 2021)

https://www.starterstory.com/best-cbd-suppliers

DR CBD signed with Susan G. Komen (@SusanGKomen) Walgreens Pavilions Albertsons & Costco is HUGE, selling in nearly 200 cali stores, ready to expand nationwide.

$MSMY is a CBD white label wholesale manufacturer. HANDS DOWN one of the most undervalued, undiscovered GEM companies in the entire OTC IMO. 455 mil float, ZERO dilution. Profitable w/ revenue in the millions growing Q over Q(40-60% growth projected Q over Q).. Twitter very active & PR's coming out steady. International exposure, operating at 75% margins.

Current Catalysts

Pink Current
Just Filed For Ticker/Name Change
Up List Soon
VERY LOW Float (456mil)
5 Year Contract "With Major Entity"
DR CBD DEAL is MASSIVE
BIG PR Coming Soon
Millions In Revenue
Growing 40%-60% Q over Q
Actively Hiring Employees & Expanding
CONFIRMED No Reverse Split!
No Dilution










Interview done by http://truthfultrading.com/

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences